About
Yaron Daniely is a General Partner at aMoon, where he co-leads Velocity, an early-stage fund focused on cutting-edge technologies aimed at accelerating cures. Before aMoon, he was President and CEO of Yissum, Hebrew University's technology transfer company, and Co-Chairperson of the Israel Technology Transfer Network, following 14 years as a senior executive (10 as CEO) at private and NASDAQ-traded biopharma and biotech companies. He holds a PhD from the Sackler Institute of Graduate Biomedical Sciences at NYU School of Medicine and an MBA from the Technion.
Invests in
BiotechDigital HealthHealthtech
Experience
- LyfegenBoard Observercurrent2022 — presentBasel, Switzerland
- Coltac Therapeutics Ltd.Investor & Chairpersoncurrent2022 — presentIsrael
- caVos BiotherapeuticsInvestor & Chairpersoncurrent2021 — presentIsrael
- Nectin TherapeuticsInvestor & Chairpersoncurrent2020 — presentIsrael
- aMoon FundGeneral Partnercurrent2019 — presentRaanana, Israel
- MetaSight DiagnosticsInvestor & Chairperson2021 — 2025Israel
- Lin HealthBoard Observer2021 — 2022Colorado, United States
- ITTN - Israel Technology Transfer OrganizationCo Chairman2018 — 2019
- Yissum Research Development Company of the Hebrew UniversityPresident & CEO2017 — 2019Jerusalem Area, Israel
- The College of Management Academic StudiesHead of Bio-MBA Program2010 — 2018Rishon Le-Tziyon, Israel
- AlcobraChairman Of The Board2017Tel Aviv Area, Israel
- AlcobraPresident & CEO2010 — 2017Tel Aviv, Israel and Plymouth Meeting, PA (USA)
- Bioblast Ltd.Director2012 — 2014Tel Aviv, Israel
- NanoCyte, Inc.President & CEO2007 — 2010
- Gamida Cell Ltd.VP Business Development2003 — 2007
- American Cancer SocietyPostdoctoral Fellow2000 — 2003
Education
- New York UniversityPh.D., Biochemistry1996 — 2000
- Technion - Israel Institute of TechnologyMBA, Entrepreneurship/Entrepreneurial Studies2000 — 2002
- NIHPost-Doc, Skin Stem Cells2001
- Weizmann Institute of SciencePost-Doc, Cancer Biology2000 — 2003
Skills & more
InvestmentsBusiness UnderstandingNew Venture FormationBoard of DirectorsDue Diligence27Competitive Intelligence15Regulatory Strategy11Start-ups55Biotechnology64Product Development32Venture Capital20Technology Transfer13
+12 more
Protein ChemistryLifesciencesLife SciencesBusiness DevelopmentCommercializationBiopharmaceuticalsEntrepreneurshipBusiness StrategyTeam ManagementStrategyManagementPharmaceutical DevelopmentFrom Yaron's professional profile.
Same school
Also attended New York University281
Gabriella GiglioHR & Executive Talent at General CatalystAndrea EchstenkamperVP of Marketing at HeavybitRami BranitzkyPartner at Sapphire VenturesZach WhiteInvestment Team at 8VCAnkita TiwariPrograms Manager at StartXUri LopatinInvestor at Khosla Ventures
+ 275 more
Also attended Technion - Israel Institute of Technology123
Roi Bar-KatManaging Director at Intel CapitalGil GorenPartner at 83NorthOren YungerInvestor at GGV CapitalGordon DaughertyCo-Founder & Chairman at Capital FactoryBoaz PeerManaging Director, Israel & Europe at Qualcomm VenturesGal GitterPartner at Alpha Partners
+ 117 more
Shared employers
Also worked at Yissum Research Development Company of the Hebrew University2
Also worked at The College of Management Academic Studies6
Riki MozesVice President, Chief People Officer at Jerusalem Venture Partners (JVP)Amit ManzurEvents and Operations Manager at Team8Guy ProssPartner at Lumir VenturesMichael LvovskyDirector of Finance at Greenfield PartnersTom GepnerInvestor at bloom venture partnersGaby RosenbergG.R. Business Management & Development Ltd. at Nielsen Innovate
Also worked at Alcobra1
Also worked at American Cancer Society14
Shila Nieves BurneyManaging Partner at Zane Venture FundKaren KnudsenAdvisor at Oncology VenturesBruce BarronFounding Partner at Origin VenturesJustin ButlerPartner at Eclipse VenturesHeather BurnettInvestor at Southwest Michigan FirstJay FerroChair of TAC, CIO, Clario at Circadian Ventures
+ 8 more
